Inogen (INGN) Non-Current Assets (2013 - 2026)
Inogen's (INGN) quarterly Non-Current Assets came in at $95.3 million in Q1 2026, down 11.55% year-on-year from $107.7 million in Q1 2025, and down 5.05% on a QoQ basis from $100.3 million in Q4 2025.
Inogen (INGN) Non-Current Assets (2013 - 2026) Analysis & Trends
Inogen (INGN) has 14 years of Non-Current Assets data on file, last reported at $95.3 million in Q1 2026.
- On a quarterly basis, Non-Current Assets fell 11.55% year-over-year to $95.3 million in Q1 2026; TTM through Mar 2026 was $407.8 million, a 8.6% decrease from a year earlier, with the FY2025 full-year figure at $100.3 million, down 9.4% from the prior year.
- Non-Current Assets for Q1 2026 stood at $95.3 million, down from $100.3 million in the prior quarter.
- Over the last five years, Non-Current Assets for INGN reached as high as $156.5 million in Q1 2022 and fell as low as $95.3 million in Q1 2026.
- Historically, Non-Current Assets has averaged $116.4 million across 5 years, with a median of $110.7 million in 2024.
- Across the five-year window, Non-Current Assets slumped 37.38% in 2022 and grew 18.66% in 2023, its largest moves.
- Year by year, Non-Current Assets stood at $100.4 million in 2022, then advanced by 18.66% to $119.1 million in 2023, then decreased by 7.05% to $110.7 million in 2024, then decreased by 9.4% to $100.3 million in 2025, then declined by 5.05% to $95.3 million in 2026.
- Per Business Quant data, the three most recent Non-Current Assets figures were $95.3 million in Q1 2026, $100.3 million in Q4 2025, and $103.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 84.92 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 32.95 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 68.24 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 35.67 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 7.09 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2.30 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 20.47 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 26.70 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 6.35 Bn |
| 10 | Inogen | 172.68 Mn | 62.51 Mn | 37.86 Mn | 95.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 95.26 Mn |
| Dec 31, 2025 | 100.33 Mn |
| Sep 30, 2025 | 103.29 Mn |
| Jun 30, 2025 | 108.92 Mn |
| Mar 31, 2025 | 107.70 Mn |
| Dec 31, 2024 | 110.73 Mn |
| Sep 30, 2024 | 113.62 Mn |
| Jun 30, 2024 | 114.13 Mn |
| Mar 31, 2024 | 116.41 Mn |
| Dec 31, 2023 | 119.13 Mn |
| Sep 30, 2023 | 118.43 Mn |
| Jun 30, 2023 | 105.13 Mn |
| Mar 31, 2023 | 102.53 Mn |
| Dec 31, 2022 | 100.40 Mn |
| Sep 30, 2022 | 151.81 Mn |
| Jun 30, 2022 | 154.62 Mn |
| Mar 31, 2022 | 156.49 Mn |
| Dec 31, 2021 | 160.33 Mn |
| Sep 30, 2021 | 177.03 Mn |
| Jun 30, 2021 | 170.61 Mn |